Stock BXRXQ BAUDAX BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Baudax Bio, Inc.

Equities

BXRXQ

US07160F4046

Delayed OTC Markets
Other stock markets
 10:35:49 2024-05-15 am EDT 		5-day change 1st Jan Change
0.00766 USD +7.89% Intraday chart for Baudax Bio, Inc. -26.67% -65.00%
Feb. 22 Baudax Bio, Inc. Filed for Bankruptcy CI
2023 Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Noble Capital Downgrades Baudax Bio to Market Perform Rating From Outperform
MT
Wall Street Set to Open Higher as Investors Await Inflation Data, Fed Rate Decision in Coming Days
MT
Oppenheimer Adjusts Baudax Bio's Price Target to $5 From $2, Maintains Outperform Rating
MT
BAUDAX BIO : Oppenheimer Adjusts Baudax Bio PT to $2 From $3, Maintains Outperform Rating
MT
BAUDAX BIO : Oppenheimer Adjusts Baudax Bio PT to $3 From $7, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BXRXQ Stock
  4. News Baudax Bio, Inc.
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW